Skip to main content
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.70
-0.29 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
8.75
+0.05 (0.57%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Kyverna Therapeutics Employees

Kyverna Therapeutics had 130 employees as of December 31, 2025. The number of employees increased by 18 or 16.07% compared to the previous year.

Employees
130
Change (1Y)
18
Growth (1Y)
16.07%
Revenue / Employee
n/a
Profits / Employee
-$1,240,823
Market Cap
526.61M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20251301816.07%
Dec 31, 20241121616.67%
Dec 31, 202396--

Related Stocks

Company Name Employees
Lyell Immunopharma 300
Rigel Pharmaceuticals 174
Sutro Biopharma 137
Ocugen 116
enGene Therapeutics 82
Tectonic Therapeutic 60
AgomAb Therapeutics NV 58
Altimmune 57
Employee Rankings

KYTX News

More News